Orion OYJ (OTCMKTS:ORINY) Sees Strong Trading Volume – Here’s What Happened

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) shares saw unusually-high trading volume on Tuesday . 521 shares traded hands during trading, an increase of 152% from the previous session’s volume of 207 shares.The stock last traded at $38.6150 and had previously closed at $39.00.

Orion OYJ Stock Performance

The company has a debt-to-equity ratio of 0.10, a current ratio of 1.77 and a quick ratio of 1.13. The firm has a market capitalization of $11.01 billion, a P/E ratio of 17.89 and a beta of 0.08. The stock’s 50 day moving average is $38.06 and its two-hundred day moving average is $38.14.

Orion OYJ (OTCMKTS:ORINY) last announced its quarterly earnings data on Thursday, April 23rd. The company reported $0.37 earnings per share (EPS) for the quarter. Orion OYJ had a net margin of 27.14% and a return on equity of 49.17%. The firm had revenue of $488.80 million for the quarter.

About Orion OYJ

Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research.

Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France.